Enabling Rapid and Agile Manufacturing Workflows for Personalized Immunotherapies with Synthetic DNA
10:00 am - Thursday 20th November 2025
• Exploring cell-free enzymatic manufacture of DNA for small, individualized batch manufacturing
• Simplifying mRNA-based PCV workflows with synthetic, ready to use, linear DNA for IVT mRNA synthesis
• Developing a synthetic personalized DNA vaccine to achieve release within six weeks in collaboration Neomatrix